Montes-Delgado R, Guerrero Riscos M A, García-Luna P P, Martín Herrera C, Pereira Cunill J L, Garrido Vázquez M, López Muñoz I, Suárez García M J, Martín-Espejo J L, Soler Junco M L, Barbosa Martín F
Servicio de Nefrología, Hospital Universitario Virgen del Rocío, Sevilla.
Rev Clin Esp. 1998 Sep;198(9):580-6.
The low-protein diet (LPD) is used in patients with advanced chronic renal failure (CRF) to improve their symptoms and decrease the progression of CRF. LPD entails the risk for caloric malnutrition, which increases protein catabolism. Two groups were obtained from a total of 33 patients with CRF with LPD (0.6 g protein/kg/day): control group (group C), which went on with the same diet, and a group S, in which a portion of proteins and calories were provided through a low-protein and hypercaloric supplement (Suplena). During 6 months the protein intake and the evolution of the nutritional status and renal function were studied and compared between both groups. Additionally, tolerance and secondary effects of the supplement were studied in group S. Twenty-two patients (eleven in each group) completed the six month follow-up. At the end of the study, group S had the nutritional parameters better preserved, came closer to the low-protein diet objective, had a better compliance with therapy and had a less marked decrease in renal function--as measured by creatinine clearance--than group C. Tolerance to supplement was good in more than 70% of patients and secondary effects--nausea, vomiting and loss of appetite--occurred in 18% of patients at the end of the 6 months. We conclude that the use of this supplement in an LPD is usually well tolerated, enhances the compliance with the diet and can be of benefit for the mebacolic-nutritional status.
低蛋白饮食(LPD)用于晚期慢性肾衰竭(CRF)患者,以改善其症状并减缓CRF的进展。LPD存在热量营养不良的风险,这会增加蛋白质分解代谢。从总共33例接受LPD(0.6克蛋白质/千克/天)的CRF患者中分为两组:对照组(C组),继续采用相同饮食;S组,通过低蛋白高热量补充剂(速补力)提供一部分蛋白质和热量。在6个月期间,研究并比较了两组患者的蛋白质摄入量、营养状况演变和肾功能。此外,还对S组患者补充剂的耐受性和副作用进行了研究。22例患者(每组11例)完成了6个月的随访。研究结束时,S组的营养参数得到更好的维持,更接近低蛋白饮食目标,对治疗的依从性更好,并且与C组相比,通过肌酐清除率衡量的肾功能下降不那么明显。超过70%的患者对补充剂耐受性良好,6个月末18%的患者出现恶心、呕吐和食欲不振等副作用。我们得出结论,在LPD中使用这种补充剂通常耐受性良好,可提高饮食依从性,并且可能有益于代谢营养状况。